Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: February 2010
-
By Sarah Fendrick — As a result of two recent blizzards in Washington DC, the city broke a record for annual snowfall on Wednesday that had stood for more than 120 years. The old record of 54.4 inches, set in 1888-89, has now been surpassed by the 54.9 inches that has fallen this winter. …
-
By Donald Zuhn — In January, the gene patenting debate returned to National Public Radio when WBUR's "On Point" became the fourth NPR program to tackle the issue since last May, when a group of patients, physicians, academic researchers, and medical societies filed suit against the U.S. Patent and Trademark Office and Myriad Genetics,…
-
By Sarah Fendrick — The U.S. Patent and Trademark Office remains closed today, February 10, 2010, due to weather. The USPTO will consider February 10, 2010 to be a "Federal holiday within the District of Columbia" under 35 U.S.C. § 21(b) and 37 C.F.R. §§ 1.6, 1.7, 1.9, 2.2(d), 2.195, and 2.196. For additional…
-
By Sarah Fendrick — On Monday and Tuesday, February 8-9, 2010, the U.S. Patent and Trademark Office was closed due to weather. As a result of the closing, the USPTO will consider each of Monday and Tuesday, February 8-9, 2010 to be a "Federal holiday within the District of Columbia" under 35 U.S.C. §…
-
By Sherri Oslick — A note to our readers: In an effort to catch up with recently filed biotech and pharma cases following a brief hiatus, Patent Docs presents this additional installment of Court Report. Teva Women's Health, Inc. v. Lupin, Ltd. et al.2:10-cv-00603; filed February 3, 2010 in the District Court of New…
-
By James DeGiulio — This week, Fate Therapeutics of San Diego, CA was issued a Notice of Allowance for U.S. Application No. 10/997,146 (U.S. Patent Application Publication No. 2008/0280362), titled "Methods for Reprogramming Somatic Cells." With a priority date of November 26, 2003, the application is believed to contain the earliest allowed claims in…
-
By Kevin E. Noonan — Newsweek has always been Avis to Time Magazine's Hertz — evidenced by an increasing difference in subscriptions (3.3 million versus 1.97 million on 2009). So it isn't surprising that the magazine needs to do something to tweak its readership, even if that something is to distort its reporting on…
-
By Sherri Oslick — A note to our readers: In an effort to catch up with recently filed biotech and pharma cases following a brief hiatus, Patent Docs presents this additional installment of Court Report. Eli Lilly and Company v. Fresenius Kabi Oncology PLC1:10-cv-00147; filed February 4, 2010 in the Southern District of Indiana…
-
By Sherri Oslick — A note to our readers: Patent Docs apologizes to our readers for the recent Court Report hiatus. This Court Reporter was away at trial and has just now been able to come up for air. We will catch our readers up in the next few postings. Patent Docs thanks our…
-
By Christopher P. Singer — On February 1, 2010, the U.S. Patent and Trademark Office issued a press release announcing President Obama's $2.3 billion budget request for the USPTO for fiscal year 2011. According to the statement, the amount of the budget request is intended to support and achieve the strategic objectives of the…
Patent Docs 